- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01524354
Depth of Anesthesia in Cardiac Surgery
September 11, 2012 updated by: Northern State Medical University
Monitoring of Anesthetic Depth During Surgical Correction of Acquired Valvular Disorders
The aim of our study was to evaluate the significance of monitoring anesthetic depth for the conduct of anesthesia and the early postoperative period in patients subjected to surgical correction of combined valvular disorders.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Our aim was to evaluate the effect of monitoring anesthetic depth on duration of postoperative mechanical ventilation and ICU stay after surgical correction of combined valvular disorders.
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- requirement of surgical correction of two or more valves
Exclusion Criteria:
- no
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Control
Patients received maintenance of anesthesia with continuous infusion of propofol according to recommendations of the manufacturer.
|
intraoperative maintenance of anesthesia with propofol under control of cerebral state index at 40-60 points
Other Names:
intraoperative maintenance of anesthesia with propofol according to recommendations of the manufacturer
Other Names:
|
|
ACTIVE_COMPARATOR: cerebral state index
Patients received continuous infusion of propofol with rate maintaining cerebral state index (CSI) between 40 and 60 points.
|
intraoperative maintenance of anesthesia with propofol under control of cerebral state index at 40-60 points
Other Names:
intraoperative maintenance of anesthesia with propofol according to recommendations of the manufacturer
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
duration of postoperative mechanical ventilation
Time Frame: 24 hours postoperatively
|
Criteria for termination of postoperative respiratory support were the following: patient able to cooperate; adequate muscular tone; SpO2 > 95% with FiO2 0.5; PaCO2 < 45 mm Hg; postoperative bleeding rate < 50 mL hr-1; stable hemodynamics without inotropic/vasopressor support; body temperature of > 35 °C.
Temporary pacing was not regarded as a contraindication for tracheal extubation.
|
24 hours postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
length of ICU stay
Time Frame: 7 days postoperatively
|
The time until 'fit for ICU discharge' criteria as well as the actual length of the ICU stay were registered.
The 'fit for ICU discharge' criteria included the following: fully oriented patient, SaO2 > 90% on room air, no episodes of severe arrhythmias, bleeding < 50 mL hr-1, diuresis > 0.5 mL kg-1 hr-1, no need for inotropic/vasopressor support and no signs of ischemia on ECG.
|
7 days postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2010
Primary Completion (ACTUAL)
December 1, 2011
Study Completion (ACTUAL)
December 1, 2011
Study Registration Dates
First Submitted
January 30, 2012
First Submitted That Met QC Criteria
January 30, 2012
First Posted (ESTIMATE)
February 1, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
September 12, 2012
Last Update Submitted That Met QC Criteria
September 11, 2012
Last Verified
September 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Depth-28
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Valve Diseases
-
National University of Ireland, Galway, IrelandNot yet recruitingSurgical Valve Replacement | AORTIC VALVE DISEASES | Valve Disease, Aortic | Valve-in-valve ProceduresIreland
-
IRCCS Policlinico S. DonatoRecruitingMitral Valve Prolapse | Myxomatous Mitral Valve DegenerationItaly
-
Michael MorontRecruitingValve Disease, Heart | Valve Replacement | Valve Heart Stenosis | Valve Regurgitation, MitralUnited States
-
Centro Cardiologico MonzinoAzienda Ospedaliero-Universitaria di Parma; Policlinico SS Annunziata di ChietiActive, not recruitingMitral Regurgitation | Mitral Valve ProlapseItaly
-
Meril Life Sciences Pvt. Ltd.Not yet recruitingAortic Valve Disease, Mitral Valve Disease, Prosthetic Heart Valve Dysfunction | Valvular Heart Disease Requiring Surgical Aortic or Mitral Valve Replacement
-
TRiCaresRecruitingCardiovascular Diseases | Heart Valve Disease | Tricuspid Valve RegurgitationBelgium, Germany
-
University of SalernoActive, not recruitingMitral Valve Failure | AORTIC VALVE DISEASESItaly
-
National Heart, Lung, and Blood Institute (NHLBI)WithdrawnHeart Failure | Aortic Valve Stenosis | Mitral Valve Regurgitation | Heart Valve Disease | Tricuspid Valve RegurgitationUnited States
-
Boston Children's HospitalRecruitingValve Disease, Heart | Valve Heart Disease | Valve Disease, AorticUnited States
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, WisconsinCompletedMitral Valve Regurgitation | Tricuspid Valve Regurgitation, Non-rheumaticUnited States
Clinical Trials on maintenance of anesthesia
-
Cliniques universitaires Saint-Luc- Université...RecruitingElectroencephalography/Drug EffectsBelgium
-
Izmir City HospitalNot yet recruitingSedoanalgesia | Consumption of Anaesthetic Agents
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHemophilia A
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityUnknown
-
Rennes University HospitalNot yet recruiting
-
Kocaeli City HospitalThe Scientific and Technological Research Council of TurkeyWithdrawnCholecystitis, ChronicTurkey
-
Lars Kristian MunckCompletedBile Acid MalabsorptionDenmark
-
Zonguldak Bulent Ecevit UniversityCompletedGeneral Anesthesia | Quality of Recovery | İnhalation AnestheticsTurkey
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...Completed
-
Clinical Academic Center (2CA-Braga)Recruiting